Amy‐Lee Bredlau
Impact in
-
- Genetic Neurodegenerative Diseases
-
- Glioma Diagnosis and Treatment
Papers in
-
- Genetic Neurodegenerative Diseases 3
- Cerebrospinal fluid and hydrocephalus 1
- Oncology 4
- CAR-T cell therapy research 3
- Co-authors
- David Oakes (1 shared paper)Richard L. Nahin (1 shared paper)Giovanni Schifitto (1 shared paper)Catherine M. Meyers (1 shared paper)H. Diana Rosas (2 shared papers)Steven M. Hersch (2 shared papers)David N. Korones (2 shared papers)Ann‐Marie Broome (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)The Journal of Pediatrics (1 paper)British Journal of Clinical Pharmacology (1 paper)Child s Nervous System (1 paper)Clinical Trials (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Amy‐Lee Bredlau
14 papers receiving 212 citations
Peers
Comparison fields: 5 of 55
- Cellular and Molecular Neuroscience 62
- Genetics 27
- Neurology 32
- Biomaterials 23
- Oncology 38
Countries citing papers authored by Amy‐Lee Bredlau
This map shows the geographic impact of Amy‐Lee Bredlau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy‐Lee Bredlau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy‐Lee Bredlau more than expected).
Fields of papers citing papers by Amy‐Lee Bredlau
This network shows the impact of papers produced by Amy‐Lee Bredlau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy‐Lee Bredlau. The network helps show where Amy‐Lee Bredlau may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy‐Lee Bredlau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 68 | |
| 2 | 2019 | 31 | |
| 3 | 2013 | 28 | |
| 4 | 2016 | 26 | |
| 5 | 2016 | 18 | |
| 6 | 2011 | 15 | |
| 7 | 2016 | 9 | |
| 8 | 2019 | 6 | |
| 9 | 2024 | 4 | |
| 10 | 2020 | 3 | |
| 11 | 2019 | 3 | |
| 12 | 2017 | 2 | |
| 13 | 2016 | 2 | |
| 14 | 2022 | 2 |
About Amy‐Lee Bredlau
Amy‐Lee Bredlau is a scholar working on Cellular and Molecular Neuroscience, Oncology, Biotechnology, Genetics and Immunology, having authored 14 papers that have together received 217 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (3 papers), CAR-T cell therapy research (3 papers), Microbial Inactivation Methods (2 papers), Immunotherapy and Immune Responses (2 papers), Glioma Diagnosis and Treatment (2 papers), Cerebrospinal fluid and hydrocephalus (1 paper), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and Meningioma and schwannoma management (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (62 citations), Genetics (27 citations), Neurology (32 citations), Biomaterials (23 citations) and Oncology (38 citations). Amy‐Lee Bredlau has collaborated with scholars based in United States and Netherlands. Frequent co-authors include David Oakes, Richard L. Nahin, Giovanni Schifitto, Catherine M. Meyers, H. Diana Rosas, Steven M. Hersch, David N. Korones, Ann‐Marie Broome, James G. Dolan and Chao Chen. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Pediatrics, British Journal of Clinical Pharmacology, Child s Nervous System and Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.